Glenmark Pharmaceuticals Limited Share Price Bombay S.E.
Stocks
GLENMARK
INE935A01035
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,248.00 INR | +1.31% |
|
+2.89% | +10.42% |
| 08-03 | Glenmark Pharmaceuticals Limited, Q1 2027 Earnings Call, Aug 03, 2026 | |
| 07-31 | India's Glenmark Pharma posts higher quarterly profit on strong demand | RE |
| Market Cap | 637B 6.7B 5.81B 5.41B 4.98B 9.4B 9.5B 63.61B 24.96B 319B 25.18B 24.62B 1,056B | P/E 2026 |
44.2x | P/E 2027 * | 27.2x |
|---|---|---|---|---|---|
| Enterprise Value | 598B 6.29B 5.45B 5.08B 4.67B 8.82B 8.92B 59.69B 23.43B 299B 23.63B 23.11B 991B | EV / Sales 2026 |
3.51x | EV / Sales 2027 * | 3.71x |
| Free-Float |
51.04% | Yield 2026 |
0.12% | Yield 2027 * | 0.17% |
Last Transcript: Glenmark Pharmaceuticals Limited
| 1 day | +1.31% | ||
| 1 week | +2.89% | ||
| Current month | +0.66% | ||
| 1 month | +1.73% | ||
| 3 months | -6.04% | ||
| 6 months | +14.81% | ||
| Current year | +10.42% |
| 1 week | 2,163 |  | 2,269.35 |
| 1 month | 2,163 | | 2,326 |
| Current year | 1,842.8 | | 2,471.05 |
| 1 year | 1,794 | | 2,471.05 |
| 3 years | 702.05 | | 2,471.05 |
| 5 years | 348.9 | | 2,471.05 |
| 10 years | 168 | | 2,471.05 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 31/12/1999 | |
Anurag Mantri
DFI | Director of Finance/CFO | 54 | 26/05/2025 |
Indrajit Bose
PSD | President | - | 14/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Cherylann Pinto
BRD | Director/Board Member | 58 | - |
| Chairman | 56 | 11/05/2011 | |
| Director/Board Member | 85 | 13/08/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.31% | +2.89% | - | - | 6.6B | |
| -1.22% | -1.86% | +18.18% | +70.33% | 49.54B | |
| -1.75% | +3.69% | +60.31% | +127.28% | 40.07B | |
| -0.08% | +0.98% | -3.72% | +20.59% | 12.4B | |
| -0.79% | +1.99% | +16.92% | +72.54% | 11.85B | |
| +1.72% | -0.76% | +31.31% | +133.18% | 9.1B | |
| +1.34% | +3.50% | +15.77% | +33.96% | 6.94B | |
| -0.26% | -4.80% | +39.24% | -14.13% | 6.88B | |
| +0.79% | +4.47% | -31.29% | +15.81% | 5.63B | |
| -2.49% | +2.85% | +30.39% | +96.77% | 4.63B | |
| Average | -0.15% | +1.61% | +19.68% | +61.82% | 16.34B | |
| Weighted average by Cap. | -0.76% | +1.74% | +27.89% | +78.80% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 153B 1.61B 1.39B 1.3B 1.2B 2.26B 2.28B 15.28B 6B 76.61B 6.05B 5.91B 254B | 168B 1.77B 1.53B 1.43B 1.31B 2.48B 2.5B 16.76B 6.58B 84.06B 6.64B 6.49B 278B |
| Net income | 20.53B 216M 187M 174M 160M 303M 306M 2.05B 804M 10.27B 811M 793M 34.02B | 23.34B 245M 213M 198M 182M 344M 348M 2.33B 914M 11.68B 922M 902M 38.68B |
| Net Debt | -39.29B -413M -358M -334M -307M -579M -586M -3.92B -1.54B -19.66B -1.55B -1.52B -65.11B | -14.47B -152M -132M -123M -113M -213M -216M -1.44B -567M -7.24B -572M -559M -23.98B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/08/26 | ₹2,248.00 | +1.31% | 16,578 |
| 04/08/26 | ₹2,219.00 | +1.85% | 15,032 |
| 03/08/26 | ₹2,178.60 | -2.45% | 42,768 |
| 31/07/26 | ₹2,233.30 | +1.93% | 22,582 |
| 30/07/26 | ₹2,191.05 | -3.13% | 15,794 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLENMARK Stock
- GLENMARK Stock
Select your edition
All financial news and data tailored to specific country editions
